JPS6127371B2 - - Google Patents
Info
- Publication number
- JPS6127371B2 JPS6127371B2 JP51001396A JP139676A JPS6127371B2 JP S6127371 B2 JPS6127371 B2 JP S6127371B2 JP 51001396 A JP51001396 A JP 51001396A JP 139676 A JP139676 A JP 139676A JP S6127371 B2 JPS6127371 B2 JP S6127371B2
- Authority
- JP
- Japan
- Prior art keywords
- agent
- mastitis
- nitrofuryl
- treating mastitis
- oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 208000004396 mastitis Diseases 0.000 claims description 46
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- -1 fatty acid aluminum salts Chemical class 0.000 claims description 18
- 238000011282 treatment Methods 0.000 claims description 16
- HOWCLZBHAPFFAN-UHFFFAOYSA-N 4-(5-nitrofuran-2-yl)-1-oxidoquinolin-1-ium-2-carboxylic acid Chemical compound C=12C=CC=CC2=[N+]([O-])C(C(=O)O)=CC=1C1=CC=C([N+]([O-])=O)O1 HOWCLZBHAPFFAN-UHFFFAOYSA-N 0.000 claims description 14
- ZBZXITYYLWDDDN-UHFFFAOYSA-N 4-(5-nitrofuran-2-yl)quinoline-2-carboxylic acid Chemical compound C=12C=CC=CC2=NC(C(=O)O)=CC=1C1=CC=C([N+]([O-])=O)O1 ZBZXITYYLWDDDN-UHFFFAOYSA-N 0.000 claims description 10
- 210000000481 breast Anatomy 0.000 claims description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 10
- 239000008158 vegetable oil Substances 0.000 claims description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 239000000194 fatty acid Substances 0.000 claims description 7
- 229930195729 fatty acid Natural products 0.000 claims description 7
- 239000003349 gelling agent Substances 0.000 claims description 7
- 235000019483 Peanut oil Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000312 peanut oil Substances 0.000 claims description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 5
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical group [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 claims description 5
- 229940063655 aluminum stearate Drugs 0.000 claims description 5
- 239000002480 mineral oil Substances 0.000 claims description 5
- 235000010446 mineral oil Nutrition 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 4
- JJCSYJVFIRBCRI-UHFFFAOYSA-K aluminum;hexadecanoate Chemical compound [Al].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O JJCSYJVFIRBCRI-UHFFFAOYSA-K 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 3
- 229950011392 sorbitan stearate Drugs 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- MAQCMFOLVVSLLK-UHFFFAOYSA-N methyl 4-(bromomethyl)pyridine-2-carboxylate Chemical compound COC(=O)C1=CC(CBr)=CC=N1 MAQCMFOLVVSLLK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 229950004959 sorbitan oleate Drugs 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 33
- 235000013336 milk Nutrition 0.000 description 26
- 239000008267 milk Substances 0.000 description 26
- 210000004080 milk Anatomy 0.000 description 26
- 239000000203 mixture Substances 0.000 description 23
- 241000283690 Bos taurus Species 0.000 description 21
- 235000013365 dairy product Nutrition 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229920000136 polysorbate Polymers 0.000 description 5
- 241000192125 Firmicutes Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- KCIPBATVWXYPPY-UHFFFAOYSA-N 2-(furan-2-yl)-3-nitroquinoline Chemical class [O-][N+](=O)C1=CC2=CC=CC=C2N=C1C1=CC=CO1 KCIPBATVWXYPPY-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- CAGGDJBSADVXFV-UHFFFAOYSA-N 1-oxidoquinolin-1-ium-2-carboxylic acid Chemical compound C1=CC=CC2=[N+]([O-])C(C(=O)O)=CC=C21 CAGGDJBSADVXFV-UHFFFAOYSA-N 0.000 description 2
- 150000001204 N-oxides Chemical class 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 244000144980 herd Species 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ASXBYYWOLISCLQ-UHFFFAOYSA-N Dihydrostreptomycin Natural products O1C(CO)C(O)C(O)C(NC)C1OC1C(CO)(O)C(C)OC1OC1C(N=C(N)N)C(O)C(N=C(N)N)C(O)C1O ASXBYYWOLISCLQ-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- GIIWGCBLYNDKBO-UHFFFAOYSA-N Quinoline 1-oxide Chemical compound C1=CC=C2[N+]([O-])=CC=CC2=C1 GIIWGCBLYNDKBO-UHFFFAOYSA-N 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000194054 Streptococcus uberis Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- ASXBYYWOLISCLQ-HZYVHMACSA-N dihydrostreptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O ASXBYYWOLISCLQ-HZYVHMACSA-N 0.000 description 1
- 229960002222 dihydrostreptomycin Drugs 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 229940115922 streptococcus uberis Drugs 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pregnancy & Childbirth (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL47633A IL47633A (en) | 1975-07-03 | 1975-07-03 | Compositions for the treatment of bovine mastitis containing 4-c5-nitro-furyl)-quinaldinic acid n-oxide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS527971A JPS527971A (en) | 1977-01-21 |
| JPS6127371B2 true JPS6127371B2 ( ) | 1986-06-25 |
Family
ID=11048319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51001396A Granted JPS527971A (en) | 1975-07-03 | 1976-01-01 | Useful compounds as medicines for animals and uses thereof |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4070469A ( ) |
| JP (1) | JPS527971A ( ) |
| AT (1) | AT346119B ( ) |
| AU (1) | AU510163B2 ( ) |
| BE (1) | BE843642A ( ) |
| CH (1) | CH601291A5 ( ) |
| DE (1) | DE2612250C3 ( ) |
| DK (1) | DK298576A ( ) |
| ES (1) | ES449874A1 ( ) |
| FI (1) | FI761885A ( ) |
| FR (1) | FR2315931A1 ( ) |
| GB (1) | GB1507643A ( ) |
| IE (1) | IE43251B1 ( ) |
| IL (1) | IL47633A ( ) |
| IT (1) | IT1063791B ( ) |
| LU (1) | LU75285A1 ( ) |
| NL (1) | NL7607231A ( ) |
| NZ (1) | NZ181336A ( ) |
| SE (1) | SE7607630L ( ) |
| ZA (1) | ZA763747B ( ) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4401666A (en) * | 1982-02-01 | 1983-08-30 | Olin Corporation | Use of metallic salts of pyridine-2-thione-N-oxide to treat or prevent bovine mastitis |
| US5101770A (en) * | 1990-11-05 | 1992-04-07 | Stevenson Dale V | Post-milking and pre-milking udder care |
| GB9819382D0 (en) * | 1998-09-04 | 1998-10-28 | Cerebrus Ltd | Chemical compounds I |
| US20040033938A1 (en) * | 2000-09-12 | 2004-02-19 | Britten Nancy J. | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| US20080153894A1 (en) * | 2002-12-19 | 2008-06-26 | Pharmacia Corporation | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL26022A (en) * | 1966-06-23 | 1971-06-23 | Haber R | Nitrofuryl quinoline derivatives |
-
1975
- 1975-07-03 IL IL47633A patent/IL47633A/xx unknown
-
1976
- 1976-01-01 JP JP51001396A patent/JPS527971A/ja active Granted
- 1976-03-23 DE DE2612250A patent/DE2612250C3/de not_active Expired
- 1976-06-23 ZA ZA763747A patent/ZA763747B/xx unknown
- 1976-06-28 US US05/700,173 patent/US4070469A/en not_active Expired - Lifetime
- 1976-06-29 FI FI761885A patent/FI761885A/fi not_active Application Discontinuation
- 1976-06-29 GB GB26938/76A patent/GB1507643A/en not_active Expired
- 1976-06-30 AU AU15461/76A patent/AU510163B2/en not_active Expired
- 1976-06-30 CH CH836876A patent/CH601291A5/xx not_active IP Right Cessation
- 1976-06-30 NL NL7607231A patent/NL7607231A/xx not_active Application Discontinuation
- 1976-06-30 BE BE168517A patent/BE843642A/xx not_active IP Right Cessation
- 1976-06-30 IE IE1430/76A patent/IE43251B1/en unknown
- 1976-06-30 NZ NZ181336A patent/NZ181336A/xx unknown
- 1976-07-01 LU LU75285A patent/LU75285A1/xx unknown
- 1976-07-02 SE SE7607630A patent/SE7607630L/ not_active Application Discontinuation
- 1976-07-02 AT AT485476A patent/AT346119B/de not_active IP Right Cessation
- 1976-07-02 IT IT24979/76A patent/IT1063791B/it active
- 1976-07-02 FR FR7620201A patent/FR2315931A1/fr active Granted
- 1976-07-02 ES ES449874A patent/ES449874A1/es not_active Expired
- 1976-07-02 DK DK298576A patent/DK298576A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IT1063791B (it) | 1985-02-11 |
| BE843642A (fr) | 1976-12-30 |
| AU510163B2 (en) | 1980-06-12 |
| IL47633A0 (en) | 1975-10-15 |
| IE43251L (en) | 1977-01-03 |
| AU1546176A (en) | 1978-01-05 |
| JPS527971A (en) | 1977-01-21 |
| NL7607231A (nl) | 1977-01-05 |
| DE2612250A1 (de) | 1977-01-13 |
| IE43251B1 (en) | 1981-01-14 |
| DE2612250C3 (de) | 1978-08-31 |
| GB1507643A (en) | 1978-04-19 |
| IL47633A (en) | 1978-08-31 |
| US4070469A (en) | 1978-01-24 |
| AT346119B (de) | 1978-10-25 |
| FI761885A ( ) | 1977-01-04 |
| SE7607630L (sv) | 1977-01-04 |
| ES449874A1 (es) | 1977-08-16 |
| DK298576A (da) | 1977-01-04 |
| ATA485476A (de) | 1978-02-15 |
| FR2315931A1 (fr) | 1977-01-28 |
| CH601291A5 ( ) | 1978-07-14 |
| NZ181336A (en) | 1978-04-28 |
| FR2315931B1 ( ) | 1979-05-18 |
| LU75285A1 ( ) | 1977-02-23 |
| ZA763747B (en) | 1977-05-25 |
| DE2612250B2 (de) | 1977-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1408034B1 (de) | Verwendung von Chinolon- und Chinolizinon-Derivaten als Chemotherapeutika | |
| US4790989A (en) | Treatment of fungal infections | |
| US4340596A (en) | Preparations for the treatment of theileriosis and their use | |
| CA2193597C (en) | Otic microbial combinations | |
| EP0231621B1 (en) | Topical pharmaceutical composition comprising pseudomonic acid or a salt or ester thereof and a corticosteroid | |
| JPS6127371B2 ( ) | ||
| AU2012207698A1 (en) | Injectable compositions for mastitis comprising an NSAID and an antibiotic in a non-aqueous solvent | |
| US4401666A (en) | Use of metallic salts of pyridine-2-thione-N-oxide to treat or prevent bovine mastitis | |
| US5120711A (en) | Synergistically active veterinary compositions and process for preparing same | |
| RU2287329C1 (ru) | Препарат для лечения послеродового гнойно-катарального эндометрита и мастита у коров и способ его применения | |
| US4610993A (en) | Use of selected pyridine-N-oxide disulfide compounds to treat or prevent bovine mastitis | |
| HU210525A9 (en) | Antimicrobial compositions | |
| KR20030033076A (ko) | 고막이 파열된 동물을 치료하기 위한 귀용 미생물 배합물 | |
| JP2020512997A (ja) | 局所用ドキシサイクリン組成物 | |
| AU2015268626C1 (en) | Injectable compositions for mastitis comprising an NSAID and an antibiotic in a non-aqueous solvent | |
| EP0193283A1 (en) | Thiazoloquinoline derivatives, process for their preparation and compositions containing them | |
| RU2741787C1 (ru) | Стабильная мягкая лекарственная форма диоксидина | |
| RU2205011C1 (ru) | Фармацевтическая композиция с антибактериальной активностью | |
| CN103705530A (zh) | 一种含有乙酰氨基阿维菌素的浇泼剂组方及其制备方法 | |
| US20240058366A1 (en) | Methods of treating mastitis with an orthosomycin antimicrobial compound | |
| US3852442A (en) | Pharmaceutical compositions containing organometallic derivatives of 6-lower alkoxy-1-phenazine 5,10-dioxide | |
| US3502773A (en) | Method for controlling ectoparasite trichomonal infestation with 6-methoxy-1-phenazinol-5,10-dioxide | |
| US3357886A (en) | Oral antiseptic composition containing 1, 3, 7-triazabicyclo [3. 3. 0] octanes | |
| BR102022002475A2 (pt) | Formulações de comprimidos de fosfomicina | |
| Scott Wilkie | Pharmacokinetics of the Bovine Formulation of Enrofloxacin (Baytril® 100) in Horses |